Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)-Reference-Cited by-同舟云学术

Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST)

Published:2019-04-29 Issue:8 Volume:145 Page:2292-2303
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Jilg Stefanie¹,Rassner Michael²,Maier Jacqueline³,Waldeck Silvia²⁴⁵,Kehl Victoria⁶,Follo Marie²,Philipp Ulrike²,Sauter Andreas⁷,Specht Katja⁸,Mitschke Jan²⁴,Lange Thoralf⁹,Bauer Sebastian¹⁰,Jost Philipp J.¹,Peschel Christian¹,Duyster Justus²⁴,Gaiser Timo¹¹,Hohenberger Peter¹²,Bubnoff Nikolas²⁴¹³^ORCID

Affiliation:

1. III Medical Department for Hematology and Oncology, Klinikum Rechts der IsarTechnische Universität München Munich Germany

2. Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of MedicineUniversity of Freiburg Freiburg Germany

3. Center for Internal Medicine, Department of Hematology/Oncology and HemostaseologyUniversity of Leipzig Leipzig Germany

4. German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ) Heidelberg Germany

5. Faculty of BiologyUniversity of Freiburg Freiburg Germany

6. Institute for Medical Informatics, Statistics, and Epidemiology, Klinikum Rechts der IsarTechnische Universität München Munich Germany

7. Department of Diagnostic and Interventional Radiology, Klinikum Rechts der IsarTechnische Universität München Munich Germany

8. Institute of Pathology, Klinikum Rechts der IsarTechnische Universität München Munich Germany

9. Asklepios Klinik Weißenfels Weißenfels Germany

10. Sarcoma Center, West German Cancer CenterUniversity Hospital Essen, University Duisburg‐Essen Essen Germany

11. Institute of Pathology, University Medical Center MannheimRuprecht‐Karl University of Heidelberg Mannheim Germany

12. Division of Surgical Oncology and Thoracic SurgeryUniversity Medical Center Mannheim, Ruprecht‐Karl University of Heidelberg Mannheim Germany

13. Department of Hematology and Oncology, Medical CenterUniversity of Schleswig Holstein Lübeck Germany

Funder

Bundesministerium für Bildung und Forschung

Novartis Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32282

Reference44 articles.

1. Gastro-intestinal stromal tumors (GIST) - Current aspects of surgical management

2. Gastrointestinale Stromatumoren (GIST)

3. Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

4. Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Meta-Analysis of 1,640 Patients

5. Follow-up results after 9 years (yrs) of the ongoing, phase II B2222 trial of imatinib mesylate (IM) in patients (pts) with metastatic or unresectable KIT+ gastrointestinal stromal tumors (GIST).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hallmarks and novel insights for gastrointestinal stromal tumors: A bibliometric analysis;European Journal of Surgical Oncology;2023-12

2. Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours;Cancers;2023-08-13

3. The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure;DARU Journal of Pharmaceutical Sciences;2023-06-15

4. Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor;The Oncologist;2023-06-14

5. Local Therapies for Metastatic Sarcoma: Why, When, and How?;American Society of Clinical Oncology Educational Book;2023-06